Company / Current Assets per Share
Zenas BioPharma, Inc. Current Assets per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.40
FY2025
5-year range
$8.40 / $225.72
FY2023-FY2025
Trend
-96.3%
vs FY2024
Sector context
#89 of 210
Health Care
What the data says
At $8.40, Zenas BioPharma, Inc.'s current assets per share ranks #89 of 210 in the Health Care sector. Declined from $39.06 to $8.40 over the past 2 years.
Based on SEC 10-K filings.
8.40 in FY2025.
Declined from $39.06 to $8.40 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 210 in Health CareTop 42% of 210This company $8.40 Sector average $170.65
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 96.3% year-over-year.
- Ranks #89 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.40 | -96.3% |
| FY2024 | $225.72 | +477.9% |
| FY2023 | $39.06 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026